Pune, Feb. 06, 2024 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global Non-Opioid Pain Treatment Market is expected to clock US$ 79.46 billion by 2031 and to grow at a CAGR of 8.3% during the forecast period.
The global Non-Opioid Pain Treatment Market is experiencing significant growth, driven by the escalating opioid crisis, the need for safer and more effective alternatives to opioid medications, and the growing emphasis on multimodal approaches to pain management. A comprehensive analysis of the market reveals a dynamic landscape dedicated to revolutionizing the treatment of acute and chronic pain conditions.
Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/nonopioid-pain-treatment-market/8455
Non-Opioid Pain Treatment Market Scope
|Market Size Value in 2022
|US$ 38.77 billion
|Revenue forecast in 2031
|US$ 79.46 billion
|Base Year for Estimation
|Drug Class, Pain Type, Route of Administration, Distribution Channel, and Region
|North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Non-opioid pain treatments encompass a diverse range of pharmacological and non-pharmacological interventions aimed at alleviating pain without the use of opioid medications. The Non-Opioid Pain Treatment Market is witnessing robust expansion as healthcare providers, policymakers, and patients seek alternatives to opioids for managing pain, reducing the risk of addiction, and improving patient outcomes.
Key Market Drivers:
- Escalating Opioid Crisis: The opioid crisis, characterized by widespread misuse, addiction, and overdose deaths associated with opioid medications, has fueled the demand for non-opioid pain treatments. Healthcare stakeholders are increasingly turning to non-opioid alternatives to address pain while minimizing the risks of opioid-related adverse effects and addiction.
- Advancements in Pain Management: Ongoing advancements in pain management strategies, including the development of novel non-opioid medications, medical devices, and integrative therapies, drive innovation in the Non-Opioid Pain Treatment Market. These advancements offer healthcare providers and patients a wider range of options for managing pain effectively and safely.
- Multimodal Approaches to Pain Management: The adoption of multimodal pain management approaches, which combine multiple therapies to target different pain mechanisms, propels the growth of the Non-Opioid Pain Treatment Market. Multimodal strategies often include a combination of non-opioid medications, such as NSAIDs, antidepressants, anticonvulsants, and physical therapies, to achieve optimal pain relief with fewer side effects.
The global Non-Opioid Pain Treatment market features a competitive landscape with key players contributing to research, development, and commercialization of non-opioid pain treatments. The report profiles major companies, offering insights into their product portfolios, market share, strategic collaborations, and recent innovations.
Challenges and Opportunities:
While the Non-Opioid Pain Treatment Market presents significant opportunities, challenges such as limited efficacy of some non-opioid therapies for certain pain conditions, regulatory hurdles, and the need for patient education about non-opioid treatment options need to be addressed. However, ongoing research, investment in innovative therapies, and the potential for market expansion in emerging economies offer avenues for growth.
Table of Content
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2022)
- MARKET DYNAMICS
- GLOBAL NON-OPIOID PAIN TREATMENT MARKET- ANALYSIS & FORECAST, BY DRUG CLASS
- Selective COX-2 Inhibitors
- Non-Selective NSAIDs
- Local Anesthetics
- GLOBAL NON-OPIOID PAIN TREATMENT MARKET- ANALYSIS & FORECAST, BY PAIN TYPE
- Chronic Pain
- Neuropathic Pain
- Inflammatory Conditions
- Post-operative Pain
- Cancer Pain
- Chronic Pain
- GLOBAL NON-OPIOID PAIN TREATMENT MARKET- ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
- GLOBAL NON-OPIOID PAIN TREATMENT MARKET- ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Browse full TOC here
The report provides a forward-looking perspective on the Dental Practice Management Software market, offering insights into potential growth opportunities, emerging trends, and factors that could shape the market in the coming years. With a focus on improving practice efficiency, enhancing patient engagement, and ensuring regulatory compliance, the global market is poised for continued innovation and adoption of advanced dental practice management solutions.
In conclusion, the report serves as a valuable resource for dental professionals and industry stakeholders, providing a comprehensive analysis of market trends, challenges, and opportunities. As dental practices increasingly embrace digital transformation to optimize operations and elevate patient care, the Dental Practice Management Software Market is expected to play a pivotal role in shaping the future of dental healthcare worldwide.
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- ‘Business Profile’ of Key Players
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8455
Browse other reports:
According to the deep-dive market assessment study by Growth Plus Reports, the global personal emergency response system market was valued at US$ 5.84 billion in 2022 and is expected to register a revenue CAGR of 5.8% to reach US$ 9.70 billion by 2031.
According to the deep-dive market assessment study by Growth Plus Reports, the global phenylketonuria market was valued at US$ 592.9 million in 2022 and is expected to register a revenue CAGR of 12.4% to reach US$ 1,697.7 million by 2031.
According to the deep-dive market assessment study by Growth Plus Reports, the global vascular plugs market was valued at US$ 117 million in 2022 and is expected to register a revenue CAGR of 5.8% to reach US$ 195.9 million by 2031.
According to the deep-dive market assessment study by Growth Plus Reports, the global veterinary antibiotics market was valued at US$ 4.76 billion in 2023 and is expected to register a revenue CAGR of 3.40% to reach US$ 6.23 billion by 2031.
According to the deep-dive market assessment study by Growth Plus Reports, the global drug-eluting balloon catheters market was valued at US$ 540 million in 2022 and is expected to register a revenue CAGR of 8.2% to reach US$ 1097 million by 2031.
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as Most Innovative Healthcare Market Research Company in 2020.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.